Literature DB >> 17522897

[Positron emission tomography in pain research. From the structure to the activity of the opiate receptor system].

T Sprenger1, G Henriksen, M Valet, S Platzer, A Berthele, T R Tölle.   

Abstract

Over the last decades, functional imaging studies have fostered our knowledge of cerebral pain processing in humans. A lively interest has been focussing on possible opioidergic mechanisms of pain transmission and modulation. Today, reliable knowledge of the in vivo distribution of opioid receptors in healthy human subjects is available from positron emission tomography (PET) studies of opioidergic neurotransmission. Gender dependent differences in receptor distribution and ligand metabolism have been demonstrated. Moreover, an increasing number of studies are reporting alterations in receptor distribution patterns in states involving painful diseases. Various acute painful challenges have also been shown to induce measurable changes in receptor availability in multiple brain areas. The perigenual anterior cingulate cortex (ACC) has been identified as one brain region with a major impact on opioidergic pain modulation. Thereby, the ACC apparently executes cortical top-down control on brainstem structures in (exogenous) pharmacological opioid analgesia. In addition, accumulating evidence suggests that non-pharmacological treatment approaches also utilize similar endogenous opioid dependent pathways to exert pain modulation. This article summarizes our current knowledge of PET studies of the opioidergic system and outlines future perspectives.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522897     DOI: 10.1007/s00482-007-0547-2

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  53 in total

1.  Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network.

Authors:  U Bingel; J Lorenz; E Schoell; C Weiller; C Büchel
Journal:  Pain       Date:  2005-12-20       Impact factor: 6.961

2.  Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging.

Authors:  Jian Kong; Randy L Gollub; Ilana S Rosman; J Megan Webb; Mark G Vangel; Irving Kirsch; Ted J Kaptchuk
Journal:  J Neurosci       Date:  2006-01-11       Impact factor: 6.167

Review 3.  Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects.

Authors:  L A Dykstra; K L Preston; G E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  1997-03       Impact factor: 4.530

4.  6-O-(2-[18F]fluoroethyl)-6-O-desmethyldiprenorphine ([18F]DPN): synthesis, biologic evaluation, and comparison with [11C]DPN in humans.

Authors:  H J Wester; F Willoch; T R Tölle; F Munz; M Herz; I Oye; J Schadrack; M Schwaiger; P Bartenstein
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

5.  Differential brain opioid receptor availability in central and peripheral neuropathic pain.

Authors:  Joseph Maarrawi; Roland Peyron; Patrick Mertens; Nicolas Costes; Michel Magnin; Marc Sindou; Bernard Laurent; Luis Garcia-Larrea
Journal:  Pain       Date:  2006-11-29       Impact factor: 6.961

6.  Evaluation of beta-endorphin secretion in patients suffering from episodic cluster headache.

Authors:  R Franceschini; M Leandri; M V Gianelli; A Cataldi; E Bruno; E Rolandi; T Barreca
Journal:  Headache       Date:  1996 Nov-Dec       Impact factor: 5.887

7.  Imaging human cerebral pain modulation by dose-dependent opioid analgesia: a positron emission tomography activation study using remifentanil.

Authors:  Klaus J Wagner; Till Sprenger; Eberhard F Kochs; Thomas R Tölle; Michael Valet; Frode Willoch
Journal:  Anesthesiology       Date:  2007-03       Impact factor: 7.892

8.  11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.

Authors:  Peter S Talbot; Raj Narendran; Eduardo R Butelman; Yiyun Huang; Kim Ngo; Mark Slifstein; Diana Martinez; Marc Laruelle; Dah-Ren Hwang
Journal:  J Nucl Med       Date:  2005-03       Impact factor: 10.057

9.  Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers.

Authors:  A K Jones; S K Luthra; B Maziere; V W Pike; C Loc'h; C Crouzel; A Syrota; T Jones
Journal:  J Neurosci Methods       Date:  1988-03       Impact factor: 2.390

10.  The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study.

Authors:  Sarah von Spiczak; Alan L Whone; Alexander Hammers; Marie-Claude Asselin; Federico Turkheimer; Tobias Tings; Svenja Happe; Walter Paulus; Claudia Trenkwalder; David J Brooks
Journal:  Brain       Date:  2005-02-23       Impact factor: 13.501

View more
  6 in total

1.  [To give or not to give, that is not the question here! Longterm administration of opioids for non-tumor pain (LONTS)].

Authors:  T R Tölle; R-D Treede; M Zenz
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

Review 2.  [Neuropathic pain and neuroplasticity in functional imaging studies].

Authors:  C Maihöfner; F T Nickel; F Seifert
Journal:  Schmerz       Date:  2010-04       Impact factor: 1.107

Review 3.  Physiopathology of Migraine: What Have We Learned from Functional Imaging?

Authors:  Antonio Russo; Marcello Silvestro; Gioacchino Tedeschi; Alessandro Tessitore
Journal:  Curr Neurol Neurosci Rep       Date:  2017-10-23       Impact factor: 5.081

4.  The effect of opioid receptor blockade on the neural processing of thermal stimuli.

Authors:  Eszter D Schoell; Ulrike Bingel; Falk Eippert; Juliana Yacubian; Kerrin Christiansen; Hilke Andresen; Arne May; Christian Buechel
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

5.  Recent progress in unraveling central nervous system processing of itch sensation.

Authors:  Florian Pfab; Michael Valet; Thomas Tölle; Heidrun Behrendt; Johannes Ring; Ulf Darsow
Journal:  World Allergy Organ J       Date:  2008-10       Impact factor: 4.084

6.  Neurometabolic correlates of depression and disability in episodic cluster headache.

Authors:  Christian L Seifert; Michael Valet; Volker Pfaffenrath; Henning Boecker; Katharina V Rüther; Thomas R Tölle; Till Sprenger
Journal:  J Neurol       Date:  2010-08-25       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.